Treace(TMCI) GlobeNewswire·2024-12-30 13:15Company Overview - Treace Medical Concepts Inc is a medical technology company focused on advancing the surgical management of bunion and related midfoot deformities [13] - The company has pioneered and patented the Lapiplasty 3D Bunion Correction System, which addresses the root cause of bunions [13] - Treace estimates that 1 1 million of the 67 million Americans affected by bunions are annual surgical candidates [13] - The company has introduced additional products including the Adductoplasty Midfoot Correction System and SpeedPlate Rapid Compression Implants [13] Product Development - The Percuplasty Percutaneous 3D Bunion Correction System represents the company's second entry into the metatarsal osteotomy segment, which accounts for approximately 70% of the 450,000 bunion surgeries performed annually in the US [2] - Full commercialization of the Percuplasty System is anticipated in the second half of 2025 [10] - The Percuplasty System follows the limited release of the Nanoplasty System, providing an additional solution in the large metatarsal osteotomy segment of the $5B+ US bunion market opportunity [12] Market Strategy - The limited market release of the Percuplasty System positions the company to significantly increase its share of the overall bunion market and expand its surgeon customer base [17] - The company aims to provide a comprehensive portfolio of instrumented 3D bunion systems to meet the evolving needs of surgeons and patients [12] - The Percuplasty System is designed to expand surgeon and patient access to the improved recovery and cosmetic benefits of percutaneous bunion surgery [15] Industry Context - Bunions are complex 3-dimensional deformities that originate from an unstable joint in the middle of the foot [13] - The metatarsal osteotomy segment is the largest segment of the bunion market [2] - There is growing patient demand for minimally invasive (MIS) bunion surgery [15]